RVL Pharmaceuticals plc Stock Price

OTCPK:RVLP.Q Community·US$111.0 Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

RVLP.Q Share Price Performance

US$0.000001

0.00 (0.00%)

US$0.000001

0.00 (0.00%)

US$0.000001

Wed, 29 Oct 25

Share PriceUS$0.000001

RVLP.Q Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks

0 Rewards

View Full Analysis

RVL Pharmaceuticals plc Key Details

Last Reported Earnings

Jun 30, 2023

Next Reporting Earnings

n/a

: 0
: 0%
: 0%
: 0%

View Full Analysis

About RVLP.Q

Founded: n/a
Employees: n/a
CEO: Brian Markison
WebsiteView website: www.rvlpharma.com

RVL Pharmaceuticals plc operates as a specialty pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.